Medicine & Life Sciences
Prostaglandin H2 Receptors Thromboxane A2
100%
Atrial Fibrillation
61%
Ranolazine
53%
Septal Occluder Device
49%
Atrioventricular Node
44%
Electric Countershock
43%
Cardiac Resynchronization Therapy
42%
Plasminogen Activators
40%
Thrombolytic Therapy
39%
Alternative Splicing
37%
Veterans
35%
Thrombin
34%
Cardiomyopathies
33%
Tail
33%
Blood Platelets
30%
Thrombosis
26%
Endothelial Cells
25%
Heart Failure
25%
Mitral Valve Stenosis
21%
Ventricular Heart Septal Defects
19%
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
19%
Hirudins
19%
Nitroglycerin
16%
Epoprostenol
16%
Heparin
15%
Warfarin
14%
Placenta
13%
Population
13%
fos Genes
13%
Implantable Defibrillators
13%
Endothelium
13%
Thromboxane A2
12%
Platelet Aggregation
11%
Fibrin Clot Lysis Time
10%
Vascular Smooth Muscle
9%
7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid
9%
Atrial Appendage
8%
Therapeutics
8%
Hospitalization
8%
Complementary DNA
7%
Thromboembolism
7%
Fibrinolysis
7%
Prostaglandin H2
7%
Heart Atria
6%
RNA
6%
DNA Primers
6%
Aspirin
6%
Umbilical Veins
6%
Molecular Structure
5%
Egtazic Acid
5%